Korea-based Medison is hoping to expand its share of the U.S. ultrasound market with systems that offer color digital imaging capability and high-end live 3D rendering of fetal and organ movements. Carrying the load for these aspirations are SonoAce
Korea-based Medison is hoping to expand its share of the U.S. ultrasound market with systems that offer color digital imaging capability and high-end live 3D rendering of fetal and organ movements. Carrying the load for these aspirations are SonoAce Pico, which is being targeted to private-practice obstetricians and gynecologists, internists, radiologists, emergency departments, and small breast-imaging centers, and flagship Accuvix XQ for routine 2D studies and high-resolution and live 3D scans. (Prototypes of the two systems were unveiled at the 2002 RSNA meeting.)
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
FDA Expands Approval of MRI-Guided Ultrasound Treatment for Patients with Parkinson’s Disease
July 9th 2025For patients with advanced Parkinson’s disease, the expanded FDA approval of the Exablate Neuro platform allows for the use of MRI-guided focused ultrasound in performing staged bilateral pallidothalamic tractotomy.